| Year |
Citation |
Score |
| 2013 |
Bray K, Gillette M, Young J, Loughran E, Hwang M, Sears JC, Vargo-Gogola T. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration. Breast Cancer Research : Bcr. 15: R91. PMID 24074261 DOI: 10.1186/Bcr3487 |
0.383 |
|
| 2013 |
Gillette M, Bray K, Blumenthaler A, Vargo-Gogola T. P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation. Plos One. 8: e65105. PMID 23717689 DOI: 10.1371/Journal.Pone.0065105 |
0.332 |
|
| 2012 |
Hwang M, Peddibhotla S, McHenry P, Chang P, Yochum Z, Park KU, Sears JC, Vargo-Gogola T. P190B RhoGAP Regulates Chromosome Segregation in Cancer Cells. Cancers. 4: 475-89. PMID 22582143 DOI: 10.3390/Cancers4020475 |
0.388 |
|
| 2012 |
Gillette M, McHenry P, Blumenthaler A, Chang P, Vargo-Gogola T. Abstract 32: P190B RhoGAP overexpression drives mammary epithelial cell proliferation by altering stromal-epithelial interactions in the developing mammary gland Cancer Research. 72: 32-32. DOI: 10.1158/1538-7445.Am2012-32 |
0.451 |
|
| 2011 |
Bray K, Brakebusch C, Vargo-Gogola T. The Rho GTPase Cdc42 is required for primary mammary epithelial cell morphogenesis in vitro. Small Gtpases. 2: 247-258. PMID 22292127 DOI: 10.4161/Sgtp.2.5.18163 |
0.385 |
|
| 2011 |
Heckman-Stoddard BM, Vargo-Gogola T, Herrick MP, Visbal AP, Lewis MT, Settleman J, Rosen JM. P190A RhoGAP is required for mammary gland development. Developmental Biology. 360: 1-10. PMID 21945077 DOI: 10.1016/J.Ydbio.2011.09.006 |
0.319 |
|
| 2010 |
McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Research : Bcr. 12: R73. PMID 20860838 DOI: 10.1186/Bcr2643 |
0.452 |
|
| 2010 |
Lynch CC, Vargo-Gogola T, Matrisian LM, Fingleton B. Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. Journal of Oncology. 2010: 530745. PMID 20628524 DOI: 10.1155/2010/530745 |
0.639 |
|
| 2010 |
Vargo-Gogola T. Putting the brakes on breast cancer: therapeutic opportunities to bring cancer stem cells and the tumor microenvironment to a screeching halt. Current Drug Targets. 11: 1041-1042. PMID 20545615 DOI: 10.2174/138945010792006834 |
0.367 |
|
| 2010 |
McHenry PR, Vargo-Gogola T. Pleiotropic Functions of Rho GTPase Signaling: a Trojan Horse or Achilles’ Heel for Breast Cancer Treatment? Current Drug Targets. 11: 1043-1058. PMID 20545614 DOI: 10.2174/138945010792006852 |
0.371 |
|
| 2010 |
McHenry PR, Park C, Chang P, Zeng E, Sears J, Vargo-Gogola T. Abstract 312: P190-B RhoGAP overexpression disrupts mitosis, alters cell polarity, and increases adhesion and invasion in mammary epithelial cells Cancer Research. 70: 312-312. DOI: 10.1158/1538-7445.Am10-312 |
0.364 |
|
| 2010 |
Bray KM, Vargo-Gogola T. Abstract 1004: Investigating the role of Cdc42 in the developing mouse mammary gland Cancer Research. 70: 1004-1004. DOI: 10.1158/1538-7445.Am10-1004 |
0.393 |
|
| 2009 |
Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Breast Cancer Research : Bcr. 11: R61. PMID 19703301 DOI: 10.1186/Bcr2352 |
0.399 |
|
| 2007 |
Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Research. 67: 6760-7. PMID 17638887 DOI: 10.1158/0008-5472.Can-07-0026 |
0.703 |
|
| 2005 |
Xian W, Schwertfeger KL, Vargo-Gogola T, Rosen JM. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. The Journal of Cell Biology. 171: 663-73. PMID 16301332 DOI: 10.1083/Jcb.200505098 |
0.469 |
|
| 2005 |
Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell. 7: 485-96. PMID 15894268 DOI: 10.1016/J.Ccr.2005.04.013 |
0.587 |
|
| 2002 |
Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Archives of Biochemistry and Biophysics. 408: 155-61. PMID 12464266 DOI: 10.1016/S0003-9861(02)00525-8 |
0.675 |
|
| 2002 |
Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Research. 62: 5559-63. PMID 12359768 |
0.656 |
|
| 2002 |
Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia (New York, N.Y.). 3: 459-68. PMID 11774028 DOI: 10.1038/Sj.Neo.7900190 |
0.686 |
|
| Show low-probability matches. |